Platinum195mQualityChecker

Platinum-195m

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity SPECT
Open selection

Utility description: Platinum-195m

Platinum-195m Quality Checker — Platinum-195m for Theranostics and Research

ℹ️  Utility checks critical parameters of Platinum-195m:
    • Radionuclidic purity (≥99.0%)
    • Pt-191 and Pt-193m impurities (≤0.5% each)
    • Radiochemical purity (≥95%)
    • Free platinum (≤5%) — NEPHROTOXICITY!
    • pH, endotoxins, sterility, heavy metals

⚠️  CRITICAL: Free platinum is highly toxic to kidneys and auditory nerve!
    Impurities of other platinum isotopes degrade image quality and dosimetry.

Usage:
  Platinum195mQualityChecker.exe                            → demo mode (console output)
  Platinum195mQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType

Example (sterility: 0=sterile, 1=contaminated):
  PT195M-CIS-2026-001,500.0,99.5,0.2,0.3,98.0,2.0,6.0,50.0,0,2,CisplatinAnalog

Supported product types:
• CisplatinAnalog — cisplatin analogs for distribution imaging
• FreeIon — biodistribution studies
• Nanoparticle — imaging of platinum-loaded nanoparticles

— WHY IS THIS NEEDED?
Platinum-195m (T½=4.02 days) is a promising isotope for theranostics (therapy + diagnosis):
• Emits gamma quanta (99 keV) and conversion/Auger electrons
• Allows visualization of platinum drug distribution (e.g., cisplatin) in the body
• Used for personalization of chemotherapy: if the drug does not accumulate in the tumor, treatment is futile
• Auger electrons have high LET (linear energy transfer) at short distances, promising for micrometastasis therapy

⚠️  CRITICAL:
• Radiochemical purity ≥95% — ensures platinum is in the form of the desired drug (e.g., cisplatin), not degraded forms.
• Free platinum ≤5% — IONIC PLATINUM (unbound to ligand) is extremely nephrotoxic and ototoxic. It is rapidly excreted by kidneys, damaging tubules. Control of free platinum is a patient safety issue!
• Radionuclidic purity ≥99.0% — impurities Pt-191 (T½=2.8 d) and Pt-193m (T½=4.33 d) create additional radiation background and distort quantitative imaging.
• pH 4.5–7.5 — for complex stability and blood compatibility.
• Endotoxins ≤175 EU/vial — standard for parenterals.
• Sterility — MANDATORY.

Key features:
• Specific control of platinum isotope impurities (Pt-191, Pt-193m)
• Strict control of free (ionic) platinum due to its high toxicity
• Support for various chemical forms (cisplatin analogs, nanoparticles)
• Assessment of suitability for theranostic application

Critical parameters:
• Radionuclidic purity: ≥99.0%
• Pt-191 impurity: ≤0.5%
• Pt-193m impurity: ≤0.5%
• Radiochemical purity: ≥95.0%
• Free platinum: ≤5.0% (CRITICAL!)
• pH: 4.5–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm

💡 Usage tips:
1. Radiochemical purity controlled by HPLC with radioactive detector.
2. Free platinum can be determined by TLC or extraction methods.
3. Platinum drugs are light and temperature sensitive; store in dark at 2-8°C.
4. Pt-195m allows SPECT imaging, although gamma energy is low (high-resolution collimator required).
5. If free platinum >5% is detected, batch is rejected due to risk of acute renal failure.

⚠️ Note: Platinum-195m is not just a diagnostic isotope, but a tool for PRECISION MEDICINE in oncology. It allows seeing whether the chemotherapy drug reaches the tumor before prescribing a toxic course. However, the toxicity of platinum itself requires strictest control of chemical form.

input.csv

BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
PT195M-CIS-2026-001,500.0,99.5,0.2,0.3,98.0,2.0,6.0,50.0,0,2,CisplatinAnalog
PT195M-NANO-2026-002,300.0,98.5,1.0,0.5,96.0,4.0,6.5,100.0,0,5,Nanoparticle
PT195M-FREE-2026-003,100.0,99.9,0.05,0.05,99.5,0.5,5.5,20.0,0,1,FreeIon

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Platinum195mQualityChecker for Platinum-195m.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of Platinum-195m:
  • • Radionuclidic purity (≥99.0%)
  • • Pt-191 and Pt-193m impurities (≤0.5% each)
  • • Radiochemical purity (≥95%)
  • • Free platinum (≤5%) — NEPHROTOXICITY!
  • • pH, endotoxins, sterility, heavy metals
  • ⚠️ CRITICAL: Free platinum is highly toxic to kidneys and auditory nerve!
  • BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
  • Example (sterility: 0=sterile, 1=contaminated):
  • • FreeIon — biodistribution studies
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥95% — ensures platinum is in the form of the desired drug (e.g., cisplatin), not degraded forms.
  • • Free platinum ≤5% — IONIC PLATINUM (unbound to ligand) is extremely nephrotoxic and ototoxic. It is rapidly excreted by kidneys, damaging tubules. Control of free platinum is a patient safety issue!
  • • Radionuclidic purity ≥99.0% — impurities Pt-191 (T½=2.8 d) and Pt-193m (T½=4.33 d) create additional radiation background and distort quantitative imaging.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Platinum-195m using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringPT195M-CIS-2026-001Batch or lot identifier used for traceability.
2TotalActivityMBqdecimal500.0Radioactivity value used for release, decay or dose-related assessment.
3RadionuclidicPurityPercentstring99.5Radionuclidic purity; a critical radiation-safety and impurity parameter.
4Platinum191ImpurityPercentstring0.2Controlled impurity or residual material.
5Platinum193mImpurityPercentstring0.3Controlled impurity or residual material.
6RadiochemicalPurityPercentstring98.0Radiochemical purity; confirms the labelled chemical form and binding quality.
7FreePlatinumPercentdecimal2.0Free radionuclide / unbound species; important for non-target uptake and toxicity.
8pHdecimal6.0Solution pH; relevant for stability, compatibility and administration.
9EndotoxinsEUdecimal50.0Bacterial endotoxins; critical for parenteral administration.
10SterilityTestflag / boolean0Sterility result; critical release parameter.
11HeavyMetalsPPMdecimal2Elemental impurity / metal residue parameter.
12ProductTypestringCisplatinAnalogControlled input parameter used by the deterministic QC rules.
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Platinum191ImpurityPercent,Platinum193mImpurityPercent,RadiochemicalPurityPercent,FreePlatinumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
PT195M-CIS-2026-001,500.0,99.5,0.2,0.3,98.0,2.0,6.0,50.0,0,2,CisplatinAnalog
PT195M-NANO-2026-002,300.0,98.5,1.0,0.5,96.0,4.0,6.5,100.0,0,5,Nanoparticle
PT195M-FREE-2026-003,100.0,99.9,0.05,0.05,99.5,0.5,5.5,20.0,0,1,FreeIon

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Platinum-195m, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "platinum195m-quality-checker",
  "api": "Platinum-195m",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "PT195M-CIS-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "TotalActivityMBq",
      "value": "500.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityPercent",
      "value": "99.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Platinum191ImpurityPercent",
      "value": "0.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Platinum193mImpurityPercent",
      "value": "0.3",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreePlatinumPercent",
      "value": "2.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "6.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH use case: generators, isotope purity and starting radionuclides

Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.

Open

RPH workflow: dosimetry and therapy planning

Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: instruments, devices and radiation safety

PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open